Published in Heart Vessels on July 07, 2017
Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial. JAMA (2008) 2.59
Histopathological findings of new in-stent lesions developed beyond five years. Catheter Cardiovasc Interv (2006) 1.99
Long-term safety and efficacy of second-generation everolimus-eluting stents compared to other limus-eluting stents and bare metal stents in patients with acute coronary syndrome. Catheter Cardiovasc Interv (2014) 1.52
Antiplatelet therapy and stent thrombosis after sirolimus-eluting stent implantation. Circulation (2009) 1.49
Retracted Drug-eluting stents for acute coronary syndrome: a meta-analysis of randomized controlled trials. PLoS One (2013) 1.39
Two-year follow-up of the quantitative angiographic and volumetric intravascular ultrasound analysis after nonpolymeric paclitaxel-eluting stent implantation: late "catch-up" phenomenon from ASPECT Study. J Am Coll Cardiol (2006) 1.03
Experimental validation of geometric and densitometric coronary measurements on the new generation Cardiovascular Angiography Analysis System (CAAS II). Cathet Cardiovasc Diagn (1993) 0.91
The late-phase inflammatory response after drug-eluting stent implantation. Heart Vessels (2013) 0.87
Short- and long-term benefits of drug-eluting stents compared to bare metal stents even in treatment for large coronary arteries. Heart Vessels (2015) 0.87
Safety and efficacy of resolute zotarolimus-eluting stents compared with everolimus-eluting stents: a meta-analysis. Circ Cardiovasc Interv (2015) 0.85
In-stent restenosis is inhibited in a bare metal stent implanted distal to a sirolimus-eluting stent to treat a long de novo coronary lesion with small distal vessel diameter. Catheter Cardiovasc Interv (2013) 0.84
Incidence and predictors of the late catch-up phenomenon after drug-eluting stent implantation. Int J Cardiol (2013) 0.82
The efficacy of everolimus-eluting stent implantation in patients with ST-segment elevation myocardial infarction: outcomes of 2-year clinical follow-up. Heart Vessels (2015) 0.81
Long-term outcomes of drug-eluting stents versus bare-metal stents in large coronary arteries. Int J Cardiol (2013) 0.81
A 2-year follow-up of a randomized multicenter study comparing a paclitaxel drug-eluting balloon with a paclitaxel-eluting stent in small coronary vessels the BELLO study. Int J Cardiol (2015) 0.81
A 10-month angiographic and 4-year clinical outcome of everolimus-eluting versus sirolimus-eluting coronary stents in patients with diabetes mellitus (the diabedES IV randomized angiography trial). Catheter Cardiovasc Interv (2015) 0.80
Drug-eluting stent implantation in patients with acute coronary syndrome - the Activity of Platelets after Inhibition and Cardiovascular Events: Optical Coherence Tomography (APICE OCT) study. EuroIntervention (2014) 0.79
Drug-eluting stents and bare metal stents in patients with NSTE-ACS: 2-year outcome from the randomised BASKET-PROVE trial. EuroIntervention (2014) 0.79
Everolimus-eluting stent implantation versus repeat paclitaxel-coated balloon angioplasty for recurrent in-stent restenosis lesion caused by paclitaxel-coated balloon failure. EuroIntervention (2015) 0.79
Long-term effect of second-generation drug-eluting stents for coronary artery disease, everolimus-eluting versus zotarolimus-eluting stents: a meta-analysis. Coron Artery Dis (2015) 0.78
Comparison of drug-eluting and bare metal stents in large coronary arteries: findings from the NHLBI dynamic registry. Catheter Cardiovasc Interv (2014) 0.78
Percutaneous coronary intervention in small coronary vessels: from balloon angioplasty to drug eluting stent era. Indian Heart J (2012) 0.77
Characteristics of patients and types of lesions in patients with drug-eluting or bare-metal stent implantation in small coronary arteries: from the FU-Registry. J Cardiol (2012) 0.77
Drug-coated balloons in the treatment of small vessel disease. Heart (2013) 0.77
Percutaneous revascularization strategies in small-vessel disease. Ann Cardiol Angeiol (Paris) (2013) 0.77
"Angiographic late catch-up" phenomenon after sirolimus-eluting stent implantation. Int J Cardiol (2011) 0.77
Comparison of first- and second-generation drug-eluting stent efficacies for treating left main and/or three-vessel disease: a propensity matched study. Heart Vessels (2016) 0.77
Safety and effectiveness of drug-eluting stents versus bare-metal stents in elderly patients with small coronary vessel disease. Arch Cardiovasc Dis (2013) 0.77
Clinical value of drug-coated balloon angioplasty for de novo lesions in patients with coronary artery disease. Int J Cardiol (2016) 0.77
Efficacy of everolimus-eluting stent implantation in patients with small coronary arteries (≤2.5 mm): outcomes of 3-year clinical follow-up. Heart Vessels (2016) 0.76
Angiographic patterns of restenosis with 2nd generation drug-eluting stent: comparative analysis from a 10-year single-center experience . Int Heart J (2014) 0.76
Late catch-up phenomenon after drug-eluting balloon angioplasty. Int J Cardiol (2013) 0.76
Mechanisms explaining the late "catch-up" phenomenon after sirolimus-eluting stent implantation. Int J Cardiol (2014) 0.76
Long-term follow-up of the platinum chromium TAXUS element (ION) stent: The PERSEUS Workhorse and Small Vessel Trial Five-Year Results. Catheter Cardiovasc Interv (2015) 0.76
Which DES is the most appropriate for very small target vessels? Experimental study of stent expandable performance with SES, PES, ZES and EES. Cardiovasc Interv Ther (2011) 0.76
Improved two-year outcomes after drug-eluting versus bare-metal stent implantation in women and men with large coronary arteries: importance of vessel size. Int J Cardiol (2013) 0.75
Comparison of Strut Coverage at 6 Months by Optical Coherence Tomography With Everolimus-Eluting Stenting of Bare-Metal Stent Restenosis Versus Stenosis of Nonstented Atherosclerotic Narrowing (from the DESERT Study). Am J Cardiol (2015) 0.75